# Contact

> Semaglutide New York correspondence — Contact and correction information for Semaglutide New York, including the current absence of a public inbox and the limits on personal health questions.

**Correspondence**

A correction should make the research account more accurate.

## No public inbox

There is no public inbox or message form connected to Semaglutide New York. This page cannot accept submissions. No reply or private correspondence is available through it.

The site is an editorial research project. It has no route for treatment requests or personal medical questions. A clinician familiar with the relevant health history is the appropriate person for those decisions.

## Specific corrections

My first concern in a disputed claim is the exact passage: the page, the sentence and the study said to support it. A useful correction identifies the mismatch and the passage in the paper that resolves it. A mistaken population, an outcome described too broadly or a unit copied incorrectly would each deserve attention.

Please leave personal health details out of material prepared for a public research site. The [reading list](/references) gathers the sources used here, and [about this site](/about) explains the editorial scope.

---

At this editorial table I argue with published research on appetite and drinking; Semaglutide New York is no business, and these essays offer no medical advice.